Bibliography: Biomarkers in Psychiatry
This section contains a compilation of recent publications that have shaped the thinking in the field as well as classic works that remain important to the subject reviewed in this issue. This bibliography has been compiled by experts in the field and members of the editorial and advisory boards. Articles from the bibliography that are reprinted in this issue are in bold type.
: Genetic approaches for the study of PTSD: advances and challenges. Neurosci Lett 2017; 649:139–146Crossref, Google Scholar
Bousman CA, Forbes M, Jayaram M, et al: Antidepressant prescribing in the precision medicine era: a prescriber’s primer on pharmacogenetic tools. BMC Psychiatry 2017; 17:60Google Scholar
: Pretreatment biomarkers predicting PTSD psychotherapy outcomes: a systematic review. Neurosci Biobehav Rev 2017; 75:140–156Crossref, Google Scholar
: Biomarkers of major depression and antidepressant treatment response: current knowledge and future outlooks. J Affect Disord. 2017 Jul 5. pii: S0165-0327(17)30671-7Google Scholar
: Candidate biomarkers in children with autism spectrum disorder: a review of MRI Studies. Neurosci Bull 2017; 33:219–237Crossref, Google Scholar
Maron E, Nutt D: Biological markers of generalized anxiety disorder. Dialogues Clin Neurosci 2017; 19:147–158Google Scholar
: Imaging and fluid biomarkers in frontotemporal dementia. Nat Rev Neurol 2017; 13:406–419Crossref, Google Scholar
: Blood-based biomarkers in Alzheimer disease: current state of the science and a novel collaborative paradigm for advancing from discovery to clinic. Alzheimers Dement 2017; 13:45–58Crossref, Google Scholar
Strawbridge R, Young AH, Cleare AJ: Biomarkers for depression: recent insights, current challenges and future prospects. Neuropsychiatr Dis Treat 2017; 13:1245–1262Google Scholar
: Progress and roadblocks in the search for brain-based biomarkers of autism and attention-deficit/hyperactivity disorder. Transl Psychiatry 2017; 7:e1218Crossref, Google Scholar
: Biological markers for anxiety disorders, OCD and PTSD—a consensus statement. Part I: neuroimaging and genetics. World J Biol Psychiatry 2016; 17:321–365Crossref, Google Scholar
: An individualized risk calculator for research in prodromal psychosis. Am J Psychiatry 2016; 173:980–988Crossref, Google Scholar
Clementz BA, Sweeney JA, Hamm JP, et al: Identification of distinct psychosis biotypes using brain-based biomarkers. Am J Psychiatry 2016; 173:373–384Google Scholar
: C-reactive protein is increased in schizophrenia but is not altered by antipsychotics: meta-analysis and implications. Mol Psychiatry 2016; 21:554–564Crossref, Google Scholar
: A meta-analysis of blood cytokine network alterations in psychiatric patients: comparisons between schizophrenia, bipolar disorder and depression. Mol Psychiatry 2016; 21:1696–1709Crossref, Google Scholar
: CSF biomarkers in neurodegenerative and vascular dementias. Prog Neurobiol 2016; 138-140:36–53Crossref, Google Scholar
: The serotonin system in autism spectrum disorder: from biomarker to animal models. Neuroscience 2016; 321:24–41Crossref, Google Scholar
: The Pharmacogenomics of Bipolar Disorder study (PGBD): identification of genes for lithium response in a prospective sample. BMC Psychiatry 2016; 16:129Crossref, Google Scholar
: Eye tracking reveals abnormal visual preference for geometric images as an early biomarker of an autism spectrum disorder subtype associated with increased symptom severity. Biol Psychiatry 2016; 79:657–666Crossref, Google Scholar
: Update on bipolar disorder biomarker candidates. Expert Rev Mol Diagn 2016; 16:1209–1220Crossref, Google Scholar
: Subcortical brain volume abnormalities in 2028 individuals with schizophrenia and 2540 healthy controls via the ENIGMA consortium. Mol Psychiatry 2016; 21:547–553Crossref, Google Scholar
: A developmental neuroscience approach to the search for biomarkers in autism spectrum disorder. Curr Opin Neurol 2016; 29:123–129Crossref, Google Scholar
: Diagnostic biomarkers for posttraumatic stress disorder: promising horizons from translational neuroscience research. Biol Psychiatry 2015; 78:344–353Crossref, Google Scholar
: The Road ahead to cure Alzheimer’s disease: development of biological markers and neuroimaging methods for prevention trials across all stages and target populations. J Prev Alzheimers Dis 2014; 1:181–202Google Scholar
: Biomarkers in autism. Front Psychiatry 2014; 5:100Crossref, Google Scholar
: Attention to eyes is present but in decline in 2-6-month-old infants later diagnosed with autism. Nature 2013; 504:427–431Crossref, Google Scholar
:
: Neuroimaging biomarkers of neurodegenerative diseases and dementia. Semin Neurol 2013; 33:386–416Crossref, Google Scholar
: Biomarkers in autism spectrum disorder: the old and the new. Psychopharmacology (Berl) 2014; 231:1201–1216Crossref, Google Scholar
: Functional biomarkers of depression: diagnosis, treatment, and pathophysiology. Neuropsychopharmacology 2011; 36:2375–2394Crossref, Google Scholar
: Clinical phenotypes of psychosis in the Bipolar-Schizophrenia Network on Intermediate Phenotypes (B-SNIP). Am J Psychiatry 2013; 170:1263–1274Crossref, Google Scholar
: Longitudinal change in CSF Tau and Aβ biomarkers for up to 48 months in ADNI. Acta Neuropathol 2013; 126:659–670Crossref, Google Scholar
: The use of biomarkers in the military: from theory to practice. Psychoneuroendocrinology 2013; 38:1912–1922Crossref, Google Scholar
